ZFP Therapeutic

Type: Product
Name: ZFP Therapeutic
First reported Aug 05 2014 - Updated Aug 06 2014 - 1 reports

Sangamo BioSciences Announces Presentation At The 2014 Wedbush Securities Life Sciences Management Access Conference

RICHMOND, Calif., Aug. 5, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Geoff Nichol, M.B., Ch.B., Sangamo's executive vice president of research and development, will provide an update on the progress of Sangamo's ... [Published PR Newswire: General Business - Aug 05 2014]
First reported Aug 05 2014 - Updated Aug 05 2014 - 3 reports

Sangamo BioSciences Announces Presentation At The 2014 Wedbush Securities Life Sciences Management Access Conference

RICHMOND, Calif., Aug. 5, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ:SGMO) announced today that Geoff Nichol, M.B., Ch.B., Sangamo's executive vice president of research and development, will provide an update on the progress of Sangamo's ... [Published Nasdaq - Aug 05 2014]
First reported Aug 05 2014 - Updated Aug 05 2014 - 1 reports

Five Sangamo Scientists Recognized By Thomson Reuters Among Most Highly Cited Researchers Worldwide Of 2014

RICHMOND, Calif."Since the company's inception, we have based the development of our zinc finger DNA-binding protein (ZFP) technology on innovative and cutting-edge science," said Edward LanphierThomson Reuters recognized over three thousand researchers, ... [Published Stock Nod - Aug 05 2014]
First reported Jun 17 2014 - Updated Jun 18 2014 - 1 reports

Sangamo BioSciences Announces Presentation At The 2014 JMP Securities Healthcare Conference

RICHMOND, Calif., June 17, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Philip Gregory, D.Phil., Sangamo's senior vice president of research and CSO, will provide an update on the progress of Sangamo's ZFP Therapeutic® ... [Published PR Newswire: General Business - Jun 17 2014]
First reported Jun 02 2014 - Updated Jun 02 2014 - 2 reports

Sangamo gets CIRM fund to support clinical trial of ZFP Therapeutic for HIVAIDS

Sangamo BioSciences (SGMO) has announced that the California Institute for Regenerative Medicine (CIRM) has granted a $5.6 million Strategic Partnership Award to fund clinical studies at City of Hope to develop a potentially curative ZFP Therapeutic. ... [Published BioPortfolio - Jun 02 2014]
First reported May 30 2014 - Updated May 30 2014 - 1 reports

Sangamo BioSciences And City of Hope Granted Strategic Partnership Award From California Institute for Regenerative Medicine To Support Clinical Trial Of Stem-Cell Based ZFP Therapeutic® For HIV/AIDS

RICHMOND, Calif., May 30, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that the California Institute for Regenerative Medicine (CIRM) has granted a $5.6 million Strategic Partnership Award to fund clinical studies at City ... [Published PR Newswire: General Business - May 30 2014]
First reported May 29 2014 - Updated May 29 2014 - 1 reports

Sangamo BioSciences Announces Presentation At The Jefferies 2014 Global Healthcare Conference

RICHMOND, Calif., May 29, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and ... [Published PR Newswire: General Business - May 29 2014]
First reported May 15 2014 - Updated May 16 2014 - 1 reports

Sangamo BioSciences Announces Presentation At The UBS Global Healthcare Conference

RICHMOND, Calif., May 15, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Geoff Nichol, M.B., Ch.B., Sangamo's executive vice president, research and development, will provide an update on the progress of Sangamo's ... [Published PR Newswire: Health - May 15 2014]
First reported May 14 2014 - Updated May 14 2014 - 1 reports

Sangamo BioSciences and Collaborators to Present Data on ZFP Therapeutic Applications and Developments at Annual Meeting of the American Society of Gene and Cell Therapy

RICHMOND, Calif., May 14, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that data from clinical, preclinical and research-stage programs focused on the development of ZFP Therapeutics® will be presented at the 17th ... [Published PR Newswire: General Business - May 14 2014]
First reported May 01 2014 - Updated May 01 2014 - 1 reports

Sangamo BioSciences Announces Presentations At Upcoming Investor Conferences

RICHMOND, Calif., May 1, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and ... [Published PR Newswire: General Business - May 01 2014]

Quotes

...Gregory. "The development of Sangamo's ZFP technology platform and recent advances that have been made in its application, would not have been possible without the hard work and dedication of Ed, Michael, Fyodor, and Jeff, as well as critical contributions from Sangamo's exceptionally talented research and development team. It is a pleasure to work with this outstanding group of scientists as we advance our ZFP technology and develop ZFP Therapeutics as genetic cures for monogenic diseases."
NEXT ARTICLE More From BioPortfolio on "Sangamo gets CIRM fund to support clinical trial of ZFP Therapeutic for HIV AIDS"

More Content

All (15) | News (5) | Reports (0) | Blogs (10) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Sangamo BioSciences Announces Presentation At T... [Published Nasdaq - Aug 05 2014]
Sangamo BioSciences Announces Presentation At T... [Published Wall Street Select - Aug 05 2014]
Sangamo BioSciences Announces Presentation At T... [Published ADVFN India - Aug 05 2014]
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: General Business - Aug 05 2014]
Five Sangamo Scientists Recognized By Thomson R... [Published Stock Nod - Aug 05 2014]
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: General Business - Jun 17 2014]
Sangamo gets CIRM fund to support clinical tria... [Published BioPortfolio - Jun 02 2014]
Sangamo gets CIRM fund to support clinical tria... [Published PBR - News - Jun 02 2014]
Sangamo BioSciences And City of Hope Granted St... [Published PR Newswire: General Business - May 30 2014]
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: General Business - May 29 2014]
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: Health - May 15 2014]
Sangamo BioSciences and Collaborators to Presen... [Published PR Newswire: General Business - May 14 2014]
Sangamo BioSciences Announces Presentations At ... [Published PR Newswire: General Business - May 01 2014]
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: General Business - Feb 26 2014]
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: Health - Feb 06 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: General Business - Aug 05 2014]
RICHMOND, Calif., Aug. 5, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Geoff Nichol, M.B., Ch.B., Sangamo's executive vice president of research and development, will provide an update on the progress of Sangamo's ...
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: General Business - Jun 17 2014]
RICHMOND, Calif., June 17, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Philip Gregory, D.Phil., Sangamo's senior vice president of research and CSO, will provide an update on the progress of Sangamo's ZFP Therapeutic® ...
Sangamo gets CIRM fund to support clinical tria... [Published PBR - News - Jun 02 2014]
Sangamo BioSciences (SGMO) has announced that the California Institute for Regenerative Medicine (CIRM) has granted a $5.6 million Strategic Partnership Award to fund clinical studies at City of Hope to develop a potentially curative ZFP Therapeutic for ...
Sangamo BioSciences And City of Hope Granted St... [Published PR Newswire: General Business - May 30 2014]
RICHMOND, Calif., May 30, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that the California Institute for Regenerative Medicine (CIRM) has granted a $5.6 million Strategic Partnership Award to fund clinical studies at City ...
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: General Business - May 29 2014]
RICHMOND, Calif., May 29, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.